Avapritinib not recommended for unresectable or metastatic gastrointestinal stromal tumours
Avapritinib not deemed cost-effective, according to NICE draft guidance.
Explore our latest news, features and educational resources in this specialist area.
See what other members have to say:
"Very useful, I have filled many gaps and gained practical knowledge."
"I feel now more confident in diagnosing the presented conditions. Really it is one of the best learning activities I have completed recently."